Omega Therapeutics, Inc. (OMGA)
NASDAQ: OMGA · Real-Time Price · USD
1.040
-0.070 (-6.31%)
At close: Nov 4, 2024, 4:00 PM
1.100
+0.060 (5.77%)
After-hours: Nov 4, 2024, 4:28 PM EST
Omega Therapeutics Employees
As of December 31, 2023, Omega Therapeutics had 94 total employees, including 93 full-time and 1 part-time employees. The number of employees decreased by 23 or -19.66% compared to the previous year.
Employees
94
Change (1Y)
-23
Growth (1Y)
-19.66%
Revenue / Employee
$67,170
Profits / Employee
-$839,319
Market Cap
57.36M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 94 | -23 | -19.66% |
Dec 31, 2022 | 117 | 37 | 46.25% |
Dec 31, 2021 | 80 | - | - |
Related Stocks
Company Name | Employees |
---|---|
111, Inc. | 1,520 |
LENSAR | 130 |
Shattuck Labs | 75 |
Syros Pharmaceuticals | 68 |
Kronos Bio | 63 |
ESSA Pharma | 50 |
Milestone Scientific | 17 |
Serina Therapeutics | 11 |
OMGA News
- 20 days ago - Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings - GlobeNewsWire
- 6 weeks ago - Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications - GlobeNewsWire
- 2 months ago - Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research - GlobeNewsWire
- 3 months ago - Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress - GlobeNewsWire
- 4 months ago - Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors - GlobeNewsWire
- 5 months ago - Omega Therapeutics To Participate In Two Upcoming Investor Conferences - GlobeNewsWire
- 5 months ago - Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer - GlobeNewsWire
- 6 months ago - Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers - GlobeNewsWire